Vicapsys Life Sciences, Inc. (VICP) stock
VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)
Close on Oct 19, 2026Market cap $13.73MP/E –Yield –
Vicapsys Life Sciences shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Vicapsys Life Sciences's shares outstanding was 34M at Sep 30, 2024. For fiscal 2023 it was 35M, up 13.0% from the year before. The highest annual figure on record is 35M in fiscal 2023.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 35M | +13.0% |
| FY2022 | Dec 31, 2022 | 31M | +73.2% |
| FY2021 | Dec 31, 2021 | 18M | +1.0% |
| FY2020 | Dec 31, 2020 | 17M | +53.3% |
| FY2019 | Dec 31, 2019 | 11M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024 | Sep 30, 2024 | 34M | -0.2% |
| Q2 FY2024 | Jun 30, 2024 | 34M | -3.2% |
| Q1 FY2024 | Mar 31, 2024 | 32M | -7.3% |
| Q4 FY2023 | Dec 31, 2023 | 35M | +12.1% |
| Q3 FY2023 | Sep 30, 2023 | 34M | +10.3% |
| Q2 FY2023 | Jun 30, 2023 | 35M | +13.2% |
| Q1 FY2023 | Mar 31, 2023 | 35M | +20.5% |
| Q4 FY2022 | Dec 31, 2022 | 31M | +72.2% |
| Q3 FY2022 | Sep 30, 2022 | 31M | +78.1% |
| Q2 FY2022 | Jun 30, 2022 | 31M | +78.1% |
| Q1 FY2022 | Mar 31, 2022 | 29M | -11.2% |
| Q4 FY2021 | Dec 31, 2021 | 18M | +3.6% |
| Q3 FY2021 | Sep 30, 2021 | 18M | +0.1% |
| Q2 FY2021 | Jun 30, 2021 | 18M | +0.1% |
| Q1 FY2021 | Mar 31, 2021 | 32M | +84.9% |
| Q4 FY2020 | Dec 31, 2020 | 17M | +25.8% |
| Q3 FY2020 | Sep 30, 2020 | 17M | +45.9% |
| Q2 FY2020 | Jun 30, 2020 | 17M | +74.0% |
| Q1 FY2020 | Mar 31, 2020 | 17M | +81.2% |
| Q4 FY2019 | Dec 31, 2019 | 14M | – |
| Q3 FY2019 | Sep 30, 2019 | 12M | – |
| Q2 FY2019 | Jun 30, 2019 | 10M | – |
| Q1 FY2019 | Mar 31, 2019 | 10M | – |
See a number that looks wrong?